The Affordable Care Act and Cancer Patients -- Winners and Losers in an Unsteady Paradigm Shift: Part 2.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 181
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2014 AND VI 3 AND IP 3
Results: 17
1
2
It's About Time: Monoclonal Antibodies for Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 179
- Publication type:
- Article
3
Investigational Angiogenesis Inhibitor Improves Survival as Second-Line Treatment in Gastric Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 178
- Publication type:
- Article
4
Treatment Paradigm for NSCLC May Be Shifting.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 176
- Publication type:
- Article
5
Molecular Monitoring Can Provide Treatment Guidance in CML.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 175
- Publication type:
- Article
6
Therapy for Castration-Resistant Prostate Cancer: Use Disease State as the Guide.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 173
- Publication type:
- Article
7
The Affordable Care Act: Where Are We Now, What's the Future?
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 171
- Publication type:
- Article
8
New Melanoma Guideline Adds BRAF Inhibitor, MEK Inhibitor to First-Line Systemic Therapy Options.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 170
- By:
- Publication type:
- Article
9
Routine Cervical Cancer Screening Warranted Beyond Age 64.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 168
- By:
- Publication type:
- Article
10
14 New Genetic Markers Predict Risk for Prostate Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 166
- By:
- Publication type:
- Article
11
Promise of Personalized Care Hinges on Reimbursement Reform.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 162
- By:
- Publication type:
- Article
12
A Win for Pediatric Cancer Research: The Gabriella Miller Kids First Research Act and Smashing Walnuts Foundation.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 160
- Publication type:
- Article
13
Perspectives on the Landscape of Personalized Medicine.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 154
- Publication type:
- Article
14
Anti-PD-1/PD-L1 Therapy: New Immunotherapy Options for Patients With a Variety of Cancers.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 144
- By:
- Publication type:
- Article
15
A Breakthrough Treatment for ALL and CLL: The New Biologic Agent, CTL019.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 138
- Publication type:
- Article
16
JAK2 V617F in a Patient With AML.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 136
- By:
- Publication type:
- Article
17
The Full Spectrum of Knowledge Driving Personalized Medicine.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 134
- By:
- Publication type:
- Article